SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022598
Filing Date
2022-08-15
Accepted
2022-08-15 08:00:54
Documents
58
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1749428
2 ex31-1.htm EX-31.1 12572
3 ex31-2.htm EX-31.2 12541
4 ex32-1.htm EX-32.1 6279
5 ex32-2.htm EX-32.2 6319
  Complete submission text file 0001493152-22-022598.txt   6120574

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE avte-20220630.xsd EX-101.SCH 28227
7 XBRL CALCULATION FILE avte-20220630_cal.xml EX-101.CAL 50456
8 XBRL DEFINITION FILE avte-20220630_def.xml EX-101.DEF 111215
9 XBRL LABEL FILE avte-20220630_lab.xml EX-101.LAB 288073
10 XBRL PRESENTATION FILE avte-20220630_pre.xml EX-101.PRE 224349
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1116420
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40544 | Film No.: 221162423
SIC: 2834 Pharmaceutical Preparations